Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial

被引:10
|
作者
Zittermann, A. [1 ]
Ernst, J. B. [1 ]
Prokop, S. [1 ]
Fuchs, U. [1 ]
Dreier, J. [2 ]
Kuhn, J. [2 ]
Berthold, H. K. [3 ]
Pilz, S. [4 ]
Gouni-Berthold, I. [5 ]
Gummert, J. F. [1 ]
机构
[1] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Herz & Diabet Zentrum NRW, Georgstr 11, D-32545 Bad Oeynhausen, Germany
[2] Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum NRW, Georgstr 11, D-32545 Bad Oeynhausen, Germany
[3] Bethel Clin EvKB, Dept Internal Med & Geriatr, Bielefeld, Germany
[4] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria
[5] Univ Cologne, Polyclin Endocrinol Diabet & Prevent Med PEDP, Cologne, Germany
关键词
Bone formation; Bone resorption; Bone turnover; Heart failure; Parathyroid hormone; Vitamin D; RANDOMIZED CONTROLLED-TRIAL; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; 25-HYDROXYVITAMIN D; UNDERCARBOXYLATED OSTEOCALCIN; CARDIAC TRANSPLANTATION; FRACTURE RISK; YOUNG-WOMEN; CALCIUM;
D O I
10.1007/s00198-017-4312-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low vitamin D status is common in patients with heart failure and may influence bone health. A daily vitamin D dose of 4000 IU (moderately high dose) for 3 years had however no effect on parameters of bone metabolism, even in patients with very low vitamin D status. Introduction Low vitamin D status is common in patients with heart failure (HF) and has been related to disturbed bone turnover. The present study investigated the effect of a daily vitamin D-3 dose of 4000 IU on bone turnover markers (BTMs) in patients with advanced HF and 25-hydroxyvitamin D (25OHD) concentrations < 75 nmol/L. Methods In this pre-specified secondary analysis of a randomized controlled trial, we assessed in 158 male HF patients (vitamin Dgroup: n = 80; placebo group: n = 78) between-group differences in calciotropic hormones (25OHD, 1,25-dihydroxyvitamin D [1,25(OH) 2D], intact parathyroid hormone [iPTH]), and BTMs (cross-linked C-telopeptide of type I collagen, bone-specific alkaline phosphatase, undercarboxylated osteocalcin). Comparisons were performed at the end of a 3-year vitamin D supplementation period with adjustments for baseline values. Results Compared with placebo, vitamin D increased 25OHD on average by 54.3 nmol/L. At study termination, 25OHD and 1,25(OH) 2D were significantly higher (P < 0.001 and P = 0.007, respectively), whereas iPTH tended to be lower in the vitamin D group than in the placebo group (P = 0.083). BTMs were initially within their reference ranges and did not differ significantly between groups at study termination, neither in the entire study cohort nor when data analysis was restricted to the subgroup of patients with initial 25OHD concentrations < 30 nmol/L (n = 54) or to patients with initial hyperparathyroidism (n = 65) (all P values > 0.05). Conclusions Adaily vitamin D-3 dose of 4000 IU did not influence BTMs. Data indicate that vitamin D supplementation will not lower bone turnover in male patients with heart failure.
引用
收藏
页码:579 / 586
页数:8
相关论文
共 50 条
  • [1] Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial
    A. Zittermann
    J. B. Ernst
    S. Prokop
    U. Fuchs
    J. Dreier
    J. Kuhn
    H. K. Berthold
    S. Pilz
    I. Gouni-Berthold
    J. F. Gummert
    [J]. Osteoporosis International, 2018, 29 : 579 - 586
  • [2] Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
    Zittermann, Armin
    Ernst, Jana B.
    Prokop, Sylvana
    Fuchs, Uwe
    Dreier, Jens
    Kuhn, Joachim
    Knabbe, Cornelius
    Boergermann, Jochen
    Berthold, Heiner K.
    Pilz, Stefan
    Gouni-Berthold, Ioanna
    Gummert, Jan F.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [3] Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial
    Zittermann, Armin
    Ernst, Jana B.
    Prokop, Sylvana
    Fuchs, Uwe
    Dreier, Jens
    Kuhn, Joachim
    Knabbe, Cornelius
    Berthold, Heiner K.
    Gouni-Berthold, Ioanna
    Gummert, Jan F.
    Boergermann, Jochen
    Pilz, Stefan
    [J]. EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (02) : 673 - 680
  • [4] Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial
    Armin Zittermann
    Jana B. Ernst
    Sylvana Prokop
    Uwe Fuchs
    Jens Dreier
    Joachim Kuhn
    Cornelius Knabbe
    Heiner K. Berthold
    Ioanna Gouni-Berthold
    Jan F. Gummert
    Jochen Börgermann
    Stefan Pilz
    [J]. European Journal of Nutrition, 2019, 58 : 673 - 680
  • [5] Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial
    Zittermann, A.
    Ernst, J. B.
    Prokop, S.
    Fuchs, U.
    Gruszka, A.
    Dreier, J.
    Kuhn, J.
    Knabbe, C.
    Berthold, H. K.
    Gouni-Berthold, I
    Pilz, S.
    Gummert, J. F.
    Paluszkiewicz, L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 280 : 117 - 123
  • [6] A 3 year post-intervention follow-up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
    Zittermann, Armin
    Ernst, Jana B.
    Prokop, Sylvana
    Fuchs, Uwe
    Berthold, Heiner K.
    Gouni-Berthold, Ioanna
    Gummert, Jan F.
    Pilz, Stefan
    [J]. ESC HEART FAILURE, 2020, 7 (06): : 3754 - 3761
  • [7] Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
    Ernst, J. B.
    Prokop, S.
    Fuchs, U.
    Dreier, J.
    Kuhn, J.
    Knabbe, C.
    Berthold, H. K.
    Pilz, S.
    Gouni-Berthold, I.
    Gummert, J. F.
    Boergermann, J.
    Zittermann, A.
    [J]. NUTRITION JOURNAL, 2017, 16
  • [8] Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
    J. B. Ernst
    S. Prokop
    U. Fuchs
    J. Dreier
    J. Kuhn
    C. Knabbe
    H. K. Berthold
    S. Pilz
    I. Gouni-Berthold
    J. F. Gummert
    J. Börgermann
    A. Zittermann
    [J]. Nutrition Journal, 16
  • [9] Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial
    Schwetz, Verena
    Trummer, Christian
    Pandis, Marlene
    Gruebler, Martin R.
    Verheyen, Nicolas
    Gaksch, Martin
    Zittermann, Armin
    Maerz, Winfried
    Aberer, Felix
    Lang, Angelika
    Treiber, Gerlies
    Friedl, Claudia
    Obermayer-Pietsch, Barbara
    Pieber, Thomas R.
    Tomaschitz, Andreas
    Pilz, Stefan
    [J]. NUTRIENTS, 2017, 9 (05)
  • [10] Vitamin D supplementation in chronic heart failure
    Gregory B. Lim
    [J]. Nature Reviews Cardiology, 2016, 13 (6) : 312 - 312